Hemostasis and Thrombosis

Course Description

Hemostasis and Thrombosis studies the role of blood vessels, platelets, and coagulation factors in normal hemostasis. It covers platelet morphology and function, laboratory tests for evaluation of platelets, and platelet disorders; coagulation factors, coagulation pathways, and inherited and acquired coagulation disorders, allowing students to evaluate normal fibrinolysis and disorders of fibrinolysis; and physiologic and pathologic coagulation inhibitors and their role in the diagnosis and management of hemorrhagic diseases. Thrombotic disorders and their management by anticoagulant and fibrinolytic therapy are explained. UWF notes that equipment fees will be assessed, that permission is required, and that MLS students are required to take the corresponding laboratory, MLS4334L, as a co-requisite.

Within the SCNS taxonomy, MLS is the Medical Laboratory Sciences prefix. The University of West Florida publishes this at 1 semester hour through the Department of Medical Laboratory Sciences, College of Health. It is offered at approximately 2 Florida institutions.

⚠ At 1 semester hour this is a compact course carrying a large and clinically dense subject, and the description shows it: normal haemostasis, platelet disorders, the coagulation cascade, fibrinolysis, inhibitors, bleeding disorders, thrombosis, and anticoagulant monitoring. Expect the pace to be brisk and the material to be examined in depth on national certification regardless of the credit weight.

Haemostasis is the best example in laboratory medicine of a system that must be balanced rather than maximised. Too little clotting and the patient bleeds; too much and they thrombose. The same laboratory tests are used to investigate both failures, and the professional skill is reading a set of results as a picture of where the balance has shifted rather than as isolated numbers.

⚠⚠ UWF runs TWO parallel MLS tracks — check which sequence you are in

• UWF publishes two distinct routes through the same subject matter. One is a split lecture-plus-laboratory sequence (for example MLS4550 with MLS4550L, MLS4625 with MLS4625L), whose prerequisites are general science courses such as PCB3063 and BCH3033. The other is a "Professional Track" of integrated 3- and 4-credit C-suffix courses (MLS4193C, MLS4221C, MLS4306C, MLS4335C, MLS4461C, MLS4463C, MLS4506C, MLS4552C, MLS4626C, MLS4631C), whose prerequisites are the MLS-internal MLS3194 and MLS3621.
• ⚠ The two tracks are not interchangeable and their prerequisites differ. A student entering through general science prerequisites lands in the split sequence; one already inside the MLS programme lands in the Professional Track.
• ⚠⚠ This is not the usual C-suffix meaning. Elsewhere in Florida, a C suffix marks an integrated lecture-plus-laboratory version of the same course. At UWF in this prefix it marks a different programme track, with different entry requirements — so reading the suffix by the statewide convention will mislead.
• Confirm with the department which sequence your programme requires before enrolling in either.

⚠ The contact-hour figure is derived — the University of West Florida publishes none

UWF's catalog publishes a credit value in semester hours, the college and department, prerequisites, co-requisites, fee notices, and a description. It does not publish contact hours, a lecture and laboratory split, or terms of offering for any course. Every contact-hour value in a UWF guide in this repository is therefore derived. The figure here applies the standard lecture convention of 15 contact hours per credit, giving 15 hours for a 1-semester-hour course. Confirm the meeting schedule with the department.

Learning Outcomes

Required Outcomes

• Describe the role of blood vessels in normal haemostasis.
• Describe platelet production, structure, and morphology.
• Describe platelet adhesion, activation, and aggregation.
• Describe laboratory tests for platelet number and function.
• Describe quantitative and qualitative platelet disorders.
• Describe the coagulation factors and their nomenclature.
• Describe the coagulation pathways and their laboratory correlates.
• Describe the cell-based model of coagulation and how it differs from the cascade.
• Perform and interpret prothrombin time and INR.
• Perform and interpret activated partial thromboplastin time.
• Interpret mixing studies to distinguish factor deficiency from inhibitor.
• Describe inherited coagulation disorders including haemophilia and von Willebrand disease.
• Describe acquired coagulation disorders including liver disease and vitamin K deficiency.
• Describe disseminated intravascular coagulation and its laboratory picture.
• Describe normal fibrinolysis and disorders of fibrinolysis.
• Describe physiologic and pathologic coagulation inhibitors.
• Describe thrombophilia and thrombotic disorders.
• Describe anticoagulant therapies and their laboratory monitoring.
• Describe fibrinolytic therapy and its monitoring.
• Correlate a set of coagulation results into a coherent clinical picture.

Optional Outcomes

• Describe factor assays and their performance.
• Describe lupus anticoagulant testing and its algorithm.
• Describe direct oral anticoagulants and their measurement challenges.
• Describe viscoelastic testing such as thromboelastography.
• Describe platelet function analysers.
• Describe heparin-induced thrombocytopenia and its investigation.

Major Topics

Required Topics

• Vascular contribution to haemostasis
• Platelet production and morphology
• Platelet adhesion, activation, aggregation
• Platelet count and function testing
• Quantitative and qualitative platelet disorders
• Coagulation factors and nomenclature
• Coagulation pathways
• The cell-based model of coagulation
• Prothrombin time and INR
• Activated partial thromboplastin time
• Mixing studies
• Haemophilia and von Willebrand disease
• Acquired coagulopathy
• Disseminated intravascular coagulation
• Fibrinolysis and its disorders
• Coagulation inhibitors
• Thrombophilia
• Anticoagulant therapy and monitoring
• Fibrinolytic therapy

Optional Topics

• Factor assays
• Lupus anticoagulant algorithms
• Direct oral anticoagulants
• Viscoelastic testing
• Platelet function analysers
• Heparin-induced thrombocytopenia

Resources & Tools

• Rodak, Hematology: Clinical Principles and Applications — the standard MLS text; its haemostasis chapters support this course.
• Keohane, Rodak's Hematology — current editions; the same lineage.
• CLSI H21 and related guidelines — specimen collection and handling for coagulation testing, where the pre-analytical requirements are unusually strict.
• ISTH (isth.org) — the International Society on Thrombosis and Haemostasis; free guidance documents and standardised definitions.
• CDC and NHLBI resources on bleeding and clotting disorders — free; good patient-level and clinician-level material.
• ASCP Board of Certification content guideline — free; haemostasis is examined within the haematology section.
• Practice result-set interpretation — the examinable skill is reading PT, aPTT, platelet count and fibrinogen together as a pattern, and it is built by working many cases.

Career Pathways

• Medical and clinical laboratory technologists and technicians — SOC 29-2011 and 29-2012; a persistent national shortage occupation, and hospital laboratories recruit continuously.
• Florida hospital systems — AdventHealth, Orlando Health, BayCare, Baptist Health, Tampa General, Jackson Health, and in UWF's own region Baptist Health Care and Ascension Sacred Heart in Pensacola.
• Reference and commercial laboratories — Quest Diagnostics and Labcorp both operate substantial Florida facilities.
• Blood centres and transfusion services — OneBlood is the major Florida blood supplier.
• Public health laboratories — the Florida Department of Health Bureau of Public Health Laboratories, which handles outbreak and reportable-disease testing.
• Molecular and genetic testing laboratories — the fastest-growing segment of the field.
• Laboratory management and supervision — SOC 11-9111 adjacent; a normal progression after several years at the bench.
• In vitro diagnostics industry — applications, technical support, and field service roles with instrument and reagent manufacturers, which typically pay more than bench work.
• Pathway to further study — medical school, physician assistant, pathology assistant, and graduate work in molecular biology or public health.
• ⚠ An honest note on the work itself. Clinical laboratory scientists are largely invisible to patients and produce the majority of the objective data on which diagnoses are made. The work is shift-based, includes nights and weekends in hospital settings, and carries real consequence — a transfusion or a critical result acted on incorrectly harms someone.

Special Information

⚠⚠ Florida licenses clinical laboratory personnel — and most states do not

• Florida is one of a small number of states that require a state licence to work as clinical laboratory personnel. Licensure is administered by the Florida Department of Health, and a national certification alone is not sufficient to practise in Florida.
• ⚠ This is the single most important regulatory fact for a Florida MLS student, and it cuts both ways: graduates of a Florida programme are prepared for it, while someone certified in a non-licensure state who moves to Florida must obtain the state licence separately.
• The usual national credential is the ASCP Board of Certification MLS credential, earned by examination after completing a programme accredited by NAACLS.
• ⚠⚠ Programmatic accreditation matters more here than institutional accreditation. Eligibility to sit the certification examination generally depends on graduating from a NAACLS-accredited programme — so confirm a programme's current accreditation status directly with NAACLS before enrolling, and be careful about assuming that transferred coursework preserves eligibility.
• Laboratory testing itself is federally regulated under CLIA, which sets personnel requirements by test complexity — the framework within which both licensure and certification sit.

⚠⚠ "Permission is required" — this course is gated on programme admission

• UWF marks this course Permission is required, and the same phrase appears on nearly every course in the MLS prefix. Meeting the listed prerequisites does not make a student eligible to enrol.
• ⚠ In practice this means admission to the Medical Laboratory Sciences programme. Clinical laboratory science programmes are cohort-based and capacity-limited, because laboratory seats and clinical placements are finite — so admission is competitive and separate from admission to the university.
• ⚠⚠ Apply to the programme early and treat its deadlines as the real constraint. A student who completes every science prerequisite and misses the cohort application waits a full year, because a cohort sequence normally starts once a year — and UWF publishes no terms of offering, so this cannot be confirmed from the catalog.
• Contact the Department of Medical Laboratory Sciences, College of Health, before planning a schedule around these courses.

⚠⚠ MLS4334 and MLS4334L are taken together

• UWF states in the description that "MLS students are required to take the corresponding laboratory, MLS4334L, as a co-requisite." This is stated in prose rather than in a co-requisite field — and the corresponding laboratory carries the formal field in return.
• ⚠⚠ Note the conditional: the requirement is stated for MLS students. A student from another programme taking this course as an elective may not be bound by it — which also means they would get the didactic content without the bench work. Confirm with the department which applies to you.
• ⚠ UWF expresses co-requisites three different ways across its catalog — an explicit Co-requisite: field, an asterisk on a prerequisite meaning may be taken prior to or during the same term, and plain prose in the description. A reader who learns only one notation will misread the others.
• Budget for the pair. The lecture and laboratory are separate enrolments with separate credit, and the laboratory carries its own fees.

⚠ Laboratory fees are assessed for this course

• UWF publishes an equipment fee notice on this entry. It is charged in addition to tuition, and the amount is not published in the course entry.
• The amounts are in the catalog's separate Material & Supply and Equipment Fees section. ⚠ Budget for them — laboratory fees are billed with tuition and are invisible when a student estimates a term's cost from credit hours alone.
• ⚠⚠ Clinical laboratory courses are among the most fee-heavy in any undergraduate programme, because reagents, controls, blood products, and analyser consumables are genuinely expensive. Ask the department for the current total across the whole MLS sequence rather than course by course — the cumulative figure is the one that matters.

⚠⚠ Coagulation is the most pre-analytically fragile testing in the laboratory

• Specimen quality determines the result more here than anywhere else. The sodium citrate tube must be filled to the mark, because the anticoagulant-to-plasma ratio is part of the method — a short-filled tube falsely prolongs clotting times.
• ⚠ A high haematocrit changes the effective ratio and requires citrate adjustment, which is a classic examination point and a real practice issue in polycythaemic patients.
• ⚠⚠ Haemolysed, clotted, or heparin-contaminated specimens are unusable. A specimen drawn from a heparinised line gives a dramatically prolonged aPTT that looks like a real finding — and has caused unnecessary investigation and delayed procedures.
• Order of draw matters because carryover of additive from another tube alters results.
• Time and temperature limits are real. Factor activity falls with delay, and specimens have defined stability windows.
• ⚠ Rejecting an inadequate coagulation specimen is correct practice, even under pressure to report something.

⚠⚠ Reading the pattern, not the number

• PT and aPTT together localise the problem. Prolonged PT with normal aPTT, the reverse, and both prolonged each point to different parts of the system — and this pattern logic is the core examinable skill.
• ⚠ Mixing studies separate deficiency from inhibitor. Correction on mixing suggests factor deficiency; failure to correct suggests an inhibitor, and the distinction changes management completely.
• ⚠⚠ The classical cascade is a laboratory model, not physiology. The intrinsic and extrinsic pathways describe what the tests measure; the cell-based model describes what actually happens in a patient, and holding both is necessary to explain why factor XII deficiency prolongs the aPTT without causing bleeding.
• A normal screening result does not exclude a bleeding disorder. Von Willebrand disease and factor XIII deficiency both commonly present with normal PT and aPTT — which is why clinical history outranks screening tests.
• ⚠ Direct oral anticoagulants confound the routine tests in ways warfarin and heparin do not, and this is an active practice problem rather than a settled one.

⚠⚠ Bloodborne pathogen exposure is a real occupational risk, and the controls are not optional

• Clinical laboratory work involves human blood and body fluids, which are treated as infectious regardless of the patient's known status. That is Standard Precautions, and it is the organising rule of laboratory practice.
• The OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) is law, not guidance — it requires an exposure control plan, personal protective equipment, engineering controls, and hepatitis B vaccination offered at no cost.
• ⚠⚠ Needlestick and sharps injuries are the highest-risk exposure route. Never recap needles by hand, dispose of sharps at the point of use, and report every exposure immediately — post-exposure prophylaxis is time-critical, and the instinct to say nothing is the dangerous one.
• Aerosol generation is the underestimated route. Uncapping tubes, centrifuge accidents, and pipetting all generate aerosols; a centrifuge that is unbalanced or opened too early is a genuine hazard.
• ⚠ Programmes normally require immunisation records, a health screening, and sometimes a background check and drug screen before clinical placement. Start these early — they take longer than students expect and can delay a placement.
• Chemical hazards sit alongside the biological ones, and both belong in the same safety habit.

⚠⚠ Quality control is the discipline, not a chore attached to it

• A result is worthless without evidence that the method was performing when it was produced. That evidence is quality control, and in clinical laboratory science it is the professional skill rather than an administrative overhead.
• ⚠ Learn Levey-Jennings charts and the Westgard rules properly. They are how a laboratory distinguishes normal analytical variation from a real shift or trend, and they are examined on the ASCP board certification.
• ⚠⚠ The consequence of releasing a result from an out-of-control run is a patient managed on a wrong number. Delta checks, critical value protocols, and result verification exist because that happens and because it harms people.
• Pre-analytical error dominates. Most laboratory errors occur before the specimen reaches the analyser — wrong patient, wrong tube, haemolysis, insufficient volume, wrong order of draw — and the laboratory is frequently blamed for errors that happened at collection.
• Accuracy, precision, sensitivity, specificity and predictive value are used precisely here, not loosely. Predictive value depends on disease prevalence, which is why the same test performs differently in different populations.

Course format and position in the curriculum

• Lecture with examinations, taken with MLS4334L for MLS majors.
• ⚠ One semester hour, and dense. The credit weight understates the content and the certification examination does not scale its coverage to the credit.
• Equipment fees are assessed.
• Leads to the haematology clinical rotation MLS4822L, where these tests are performed on real patients.
• UWF publishes no contact hours, lecture and laboratory split, or terms of offering for any course. Confirm the offering pattern with the department.

How Florida course levels affect transfer

The first digit of an SCNS number denotes the year of offering, not transferability. Courses at the 1000 and 2000 levels transfer transparently between Florida public institutions, and 3000 to 4000 is unproblematic since both are upper division. The boundary that actually matters is 2000 to 3000, where lower-division credit generally cannot satisfy an upper-division requirement. ⚠ For clinical laboratory sciences the more important constraint is programmatic rather than numeric: courses are gated on admission to a cohort, sequenced tightly, and tied to NAACLS accreditation and to eligibility for certification — so transferring individual courses between programmes is frequently not possible even where the credit itself articulates.

MLS4334 is 1 semester hour at the University of West Florida, taken with the 1-semester-hour MLS4334L by MLS majors.